Home › Cardiovascular Disease › Ohio › Akron
Cardiovascular Disease clinical trials in Akron, OH
3 studies for Cardiovascular Disease are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Aultman Hospital, Canton · 21 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Akron Hospital Summa Health System, Akron
- Aultman Hospital, Canton · 21 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Aultman Cardiology Clinical Trials, Canton · 21 mi away
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Akron
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer16 studies
- Cancer (all types)13 studies
- Breast Cancer13 studies
- Prostate Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Melanoma8 studies
- Small Cell Lung Cancer8 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Steatotic Liver Disease7 studies
- Endometrial Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.